• Exchange: Berlin
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Navamedic ASA

+ Add to Watchlist

N1A:GR

1.525 EUR 0.001 0.07%

As of 02:01:27 ET on 09/01/2014.

Snapshot for Navamedic ASA (N1A)

Open: 1.525 Day's Range: 1.525 - 1.525 Volume: 0
Previous Close: 1.526 52wk Range: 1.220 - 1.890 1-Yr Rtn: +5.17%

Stock Chart for N1A

No chart data available.
  • N1A:GR 1.525
  • 1D
  • 1M
  • 1Y
1.526
Interactive N1A Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for N1A

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (NOK) (ttm) -
Est. EPS (NOK) (12/2014) -
Est. PEG Ratio -
Market Cap (M EUR) 13.06
Shares Outstanding (M) 8.56
30 Day Average Volume 0
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend (NOK) -
Dividend Ex-Date 05/07/2012
5 Year Dividend Growth -
Next Earnings Announcement 10/31/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for N1A

  • Revenue
  • Net Income (M/NOK)
  • Profit Margin (%)

Company Profile & Key Executives for N1A

Navamedic ASA is a pharmaceutical company focusing on the development and production of glucosamine HCl (hydrochloride) based medicines.

Hakan JosephssonInterim CEO/Head:Nordic OperationsBjorn LindholtChief Financial Officer
Per Anders ElvertroCCO/Head:Regulatory AffairsOlof MilvedenStrategic Advisor
More Company Profile & Key Executives for N1A

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil